As of 2026-09-17, the Relative Valuation of Maravai LifeSciences Holdings Inc (MRVI) is (8.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.84 USD, the upside of Maravai LifeSciences Holdings Inc based on Relative Valuation is -229.3%.
The range of the Relative Valuation is (9.06) - (8.48) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.2x - 33.8x | 30.8x |
| Forward P/E multiples | 26.3x - 28.3x | 28.2x |
| Fair Price | (9.06) - (8.48) | (8.84) |
| Upside | -232.5% - -223.9% | -229.3% |
| Date | P/E |
| 2026-09-16 | -22.82 |
| 2026-09-15 | -22.95 |
| 2026-09-14 | -22.30 |
| 2026-09-11 | -21.79 |
| 2026-09-10 | -22.45 |
| 2026-09-09 | -23.19 |
| 2026-09-08 | -23.99 |
| 2026-09-04 | -24.42 |
| 2026-09-03 | -24.59 |
| 2026-09-02 | -24.62 |
| 2026-09-01 | -24.36 |
| 2026-08-31 | -25.49 |
| 2026-08-28 | -25.62 |
| 2026-08-27 | -27.93 |
| 2026-08-26 | -29.69 |
| 2026-08-25 | -30.03 |
| 2026-08-24 | -28.13 |
| 2026-08-21 | -28.83 |
| 2026-08-20 | -27.66 |
| 2026-08-19 | -24.09 |
| 2026-08-18 | -19.15 |
| 2026-08-17 | -18.95 |
| 2026-08-14 | -19.02 |
| 2026-08-13 | -19.28 |
| 2026-08-12 | -19.28 |
| 2026-08-11 | -19.38 |
| 2026-08-10 | -20.25 |
| 2026-08-07 | -20.79 |
| 2026-08-06 | -20.85 |
| 2026-08-05 | -21.39 |
| 2026-08-04 | -21.45 |
| 2026-08-03 | -21.42 |
| 2026-07-31 | -21.92 |
| 2026-07-30 | -22.52 |
| 2026-07-29 | -21.99 |
| 2026-07-28 | -22.89 |
| 2026-07-27 | -22.32 |
| 2026-07-24 | -22.55 |
| 2026-07-23 | -23.52 |
| 2026-07-22 | -23.69 |
| 2026-07-21 | -23.69 |
| 2026-07-20 | -23.32 |
| 2026-07-17 | -24.16 |
| 2026-07-16 | -23.66 |
| 2026-07-15 | -23.49 |
| 2026-07-14 | -21.72 |
| 2026-07-13 | -21.22 |
| 2026-07-10 | -20.32 |
| 2026-07-09 | -19.92 |
| 2026-07-08 | -19.22 |